Literature DB >> 27154819

Towards understanding pre-mRNA splicing mechanisms and the role of SR proteins.

Mahbod Sahebi1, Mohamed M Hanafi2, Andre J van Wijnen3, Parisa Azizi4, Rambod Abiri5, Sadegh Ashkani6, Sima Taheri7.   

Abstract

Alternative pre-mRNA splicing provides a source of vast protein diversity by removing non-coding sequences (introns) and accurately linking different exonic regions in the correct reading frame. The regulation of alternative splicing is essential for various cellular functions in both pathological and physiological conditions. In eukaryotic cells, this process is commonly used to increase proteomic diversity and to control gene expression either co- or post-transcriptionally. Alternative splicing occurs within a megadalton-sized, multi-component machine consisting of RNA and proteins; during the splicing process, this complex undergoes dynamic changes via RNA-RNA, protein-protein and RNA-protein interactions. Co-transcriptional splicing functionally integrates the transcriptional machinery, thereby enabling the two processes to influence one another, whereas post-transcriptional splicing facilitates the coupling of RNA splicing with post-splicing events. This review addresses the structural aspects of spliceosomes and the mechanistic implications of their stepwise assembly on the regulation of pre-mRNA splicing. Moreover, the role of phosphorylation-based, signal-induced changes in the regulation of the splicing process is demonstrated.
Copyright © 2016 Elsevier B.V. All rights reserved.

Keywords:  Co-transcriptional splicing; Post-transcriptional splicing; Pre-mRNA splicing; SR proteins

Mesh:

Substances:

Year:  2016        PMID: 27154819     DOI: 10.1016/j.gene.2016.04.057

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  23 in total

Review 1.  How do messenger RNA splicing alterations drive myelodysplasia?

Authors:  Poorval Joshi; Stephanie Halene; Omar Abdel-Wahab
Journal:  Blood       Date:  2017-03-27       Impact factor: 22.113

2.  Anti-influenza effect and action mechanisms of the chemical constituent gallocatechin-7-gallate from Pithecellobium clypearia Benth.

Authors:  Chao Li; Lv-Jie Xu; Wen-Wen Lian; Xiao-Cong Pang; Hao Jia; Ai-Lin Liu; Guan-Hua Du
Journal:  Acta Pharmacol Sin       Date:  2018-05-25       Impact factor: 6.150

Review 3.  Splicing factor mutations in MDS RARS and MDS/MPN-RS-T.

Authors:  Akihide Yoshimi; Omar Abdel-Wahab
Journal:  Int J Hematol       Date:  2017-05-02       Impact factor: 2.490

4.  Molecular Pathways: Understanding and Targeting Mutant Spliceosomal Proteins.

Authors:  Akihide Yoshimi; Omar Abdel-Wahab
Journal:  Clin Cancer Res       Date:  2016-11-10       Impact factor: 12.531

Review 5.  A Challenging Pie to Splice: Drugging the Spliceosome.

Authors:  Brian León; Manoj K Kashyap; Warren C Chan; Kelsey A Krug; Januario E Castro; James J La Clair; Michael D Burkart
Journal:  Angew Chem Int Ed Engl       Date:  2017-08-15       Impact factor: 15.336

6.  Expression of mutant DISC1 in Purkinje cells increases their spontaneous activity and impairs cognitive and social behaviors in mice.

Authors:  Alexey V Shevelkin; Chantelle E Terrillion; Bagrat N Abazyan; Tymoteusz J Kajstura; Yan A Jouroukhin; Gay L Rudow; Juan C Troncoso; David J Linden; Mikhail V Pletnikov
Journal:  Neurobiol Dis       Date:  2017-04-06       Impact factor: 5.996

Review 7.  Impacts and mechanisms of alternative mRNA splicing in cancer metabolism, immune response, and therapeutics.

Authors:  Qiu Peng; Yujuan Zhou; Linda Oyang; Nayiyuan Wu; Yanyan Tang; Min Su; Xia Luo; Ying Wang; Xiaowu Sheng; Jian Ma; Qianjin Liao
Journal:  Mol Ther       Date:  2021-11-15       Impact factor: 11.454

8.  Esrp1 is a marker of mouse fetal germ cells and differentially expressed during spermatogenesis.

Authors:  Shaghayegh Saeidi; Farnaz Shapouri; Robb U de Iongh; Franca Casagranda; Jessie M Sutherland; Patrick S Western; Eileen A McLaughlin; Mary Familari; Gary R Hime
Journal:  PLoS One       Date:  2018-01-11       Impact factor: 3.240

Review 9.  LOX-1 and Its Splice Variants: A New Challenge for Atherosclerosis and Cancer-Targeted Therapies.

Authors:  Barbara Rizzacasa; Elena Morini; Sabina Pucci; Michela Murdocca; Giuseppe Novelli; Francesca Amati
Journal:  Int J Mol Sci       Date:  2017-01-29       Impact factor: 5.923

10.  SRSF7 knockdown promotes apoptosis of colon and lung cancer cells.

Authors:  Yu Fu; Yingze Wang
Journal:  Oncol Lett       Date:  2018-02-16       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.